Biochemical failure does not predict overall survival after radical prostatectomy for localized prostate cancer: 10-year results (Q44644044)

5 December 2017

title

Biochemical failure does not predict overall survival after radical prostatectomy for localized prostate cancer: 10-year results (English)

1 reference

5 December 2017

1 reference

Jhaveri FM

1

1 reference

5 December 2017

Zippe CD

series ordinal

2

1 reference

5 December 2017

Klein EA

series ordinal

3

1 reference

5 December 2017

Kupelian PA

series ordinal

4

1 reference

5 December 2017

language of work or name

English

0 references

publication date

1 November 1999

1 reference

5 December 2017

1 reference

5 December 2017

volume

54

1 reference

5 December 2017

issue

5

1 reference

5 December 2017

page(s)

884-890

1 reference

The value of serum prostate specific antigen determinations before and after radical prostatectomy

5 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900252-6

7 January 2021

Prostate Specific Antigen and Local Recurrence after Radical Prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900252-6

7 January 2021

Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. II. Radical prostatectomy treated patients

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900252-6

7 January 2021

Prostate specific antigen levels after radical prostatectomy in patients with organ confined and locally extensive prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900252-6

7 January 2021

The incidence of prostate cancer progression with undetectable serum prostate specific antigen in a series of 394 radical prostatectomies

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900252-6

7 January 2021

Natural history of progression after PSA elevation following radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900252-6

7 January 2021

Hazard rates for progression after radical prostatectomy for clinically localized prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900252-6

7 January 2021

Long-Term (15 Years) Results After Radical Prostatectomy For Clinically Localized (Stage T2c Or Lower) Prostate Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900252-6

7 January 2021

Correlation of clinical and pathologic factors with rising prostate-specific antigen profiles after radical prostatectomy alone for clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900252-6

7 January 2021

Is prostate specific antigen of clinical importance in evaluating outcome after radical prostatectomy.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900252-6

7 January 2021

Long-term evaluation of radical prostatectomy as treatment for clinical stage C (T3) prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900252-6

7 January 2021

Impact of Radical Prostatectomy in the Management of Clinically Localized Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900252-6

7 January 2021

Prostatic Specific Antigen Related to Clinical Status 1 to 14 Years after Radical Retropubic Prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900252-6

7 January 2021

Recurrence patterns after radical retropubic prostatectomy: clinical usefulness of prostate specific antigen doubling times and log slope prostate specific antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900252-6

7 January 2021

The Incidence and Significance of Detectable Levels of Serum Prostate Specific Antigen After Radical Prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900252-6

7 January 2021

Survival after radical retropubic prostatectomy of men with clinically localized high grade carcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900252-6

7 January 2021

Results of radical prostatectomy in men with clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900252-6

7 January 2021

Results of conservative management of clinically localized prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900252-6

7 January 2021

Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900252-6

7 January 2021

Population-based study of long-term survival in patients with clinically localised prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900252-6

7 January 2021

Radical prostatectomy for high grade disease: a reevaluation 1994

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900252-6

7 January 2021

Incidence and significance of positive margins in radical prostatectomy specimens

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900252-6

7 January 2021

Prognostic significance of positive surgical margins in radical prostatectomy specimens

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900252-6

7 January 2021

Pathological features and prognostic significance of prostate cancer in the apical section determined by whole mount histology

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900252-6

7 January 2021

Declining rates of extracapsular extension after radical prostatectomy: evidence for continued stage migration

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900252-6

7 January 2021

The changing pattern of prostate cancer at the time of diagnosis: characteristics of screen detected prostate cancer in a population based screening study.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900252-6

7 January 2021

10.1016/S0090-4295(99)00252-6

Identifiers

DOI

1 reference

release_mivbkh3wlja4lf7iwosrd5dfvy

5 December 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/mivbkh3wlja4lf7iwosrd5dfvy

24 November 2022

mapped directly with Wikidata item

1 reference